Beyond Air (XAIR) Total Debt Growth (1y) (2016 - 2026)
Beyond Air (XAIR) Total Debt Growth (1y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 142.67% |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | -9.88% |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | -1.95% |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 1,188.16% |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 0.12% |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | -17.79% |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | -9.03% |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | -0.50% |
| 10 | Beyond Air | 3.72 Mn | -7.19 Mn | 225,000.00 | 127.30% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 127.30% |
| Mar 31, 2026 | -32.49% |
| Dec 31, 2025 | 150.56% |
| Sep 30, 2025 | -9.94% |
| Jun 30, 2025 | -36.35% |
| Mar 31, 2025 | -92.35% |
| Dec 31, 2024 | -39.56% |
| Sep 30, 2024 | -21.80% |
| Jun 30, 2024 | 8.69% |
| Mar 31, 2024 | 1,634.19% |
| Dec 31, 2023 | 7,155.00% |
| Sep 30, 2023 | 197.69% |
| Jun 30, 2023 | 1,639.19% |
| Mar 31, 2023 | -20.59% |
| Dec 31, 2022 | -13.04% |
| Sep 30, 2022 | 1,617.86% |
| Jun 30, 2022 | 17.28% |
| Mar 31, 2022 | -77.59% |
| Dec 31, 2021 | -95.81% |
| Sep 30, 2021 | -93.76% |